TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors. October 26, 2001
TCL Archive Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton September 6, 1996